Patent Validity Expert Witnesses

Fort Smith, Arkansas

Engineering, Intellectual Property - Mechanical Engineering Expert, Intellectual Property, Patent Validity, Human Factors Expert, Product Liability, Mechanical Design Expert Witness, Patent Litigation, Safety, Patent Infringement Expert, Industrial Engineering Expert

Dr. David C. Paulus is a nationally recognized expert in mechanical engineering, human factors, and product design, with over two decades of academic, research, and litigation consulting experience. He holds a Ph.D. in Mechanical Engineering from Colorado State University, complemented by a Master’s in Industrial Engineering and a Bachelor's in Mechanical Engineering from the University of Tennessee. He currently serves as a Professor of Practice and Director of Graduate Programs in Engineering and Operations Management at the University of Arkansas, Dr. Paulus is a Professional Engineer (PE) and Certified Human Factors Engineering Professional (CHFEP). Dr. Paulus offers an exceptional blend of technical depth and legal acumen, having served as an expert witness in over 30 product liability and patent litigation matters, including high-profile cases involving Peloton, Big Ass Fans, ICON Health & Fitness, and Mad Dogg Athletics, among others. His expert testimony spans federal and ...

Austin, Texas

Oncology, Pharmaceutical Regulation - Oncology Drug Development, Patent Validity, ICH GCP, Written description, Enablement, Obviousness, Anticipation, Pharmacology, FDA, EMA, NMPA/China, PMDA/Japan, Drug formulation, Medical Safety, Phase 1-3 Clinical Trials, Drug Product Safety, Medical Oncology, Breach of Contract - Pharma/Biotech, Commercially Reasonable Efforts, Damages

Dr. Frederick (Fred) Hausheer is a physician-scientist with over 37 years of executive leadership and management experience in US and international (EU, JP, China, others) commercial pharmaceutical research and development (Phase I-III), preclinical translational and clinical medicine, clinical pharmacology, ICH GCP compliance and commercial development strategy and risk management of novel cancer therapeutics. His commercial research and development experience includes cytotoxic agents, targeted agents, immuno-oncology therapeutics, cell therapies (BMT, CAR-T), and supportive care medicines. He is an inventor/co-inventor on more than 400 issued United States and international pharmaceutical patents, and author/co-author of more than 200 scientific/medical publications. He is an experienced former CEO and Chief Medical Officer with several biopharma companies and a former NCI-Designated Clinical Investigator, NCI-Institutional Review Board voting member, and NCI-Experimental Ther...